Original Research
Published on 05 Jul 2019
Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00764
- 5,714 views
- 13 citations

